Patents by Inventor Catherine OWCZAREK

Catherine OWCZAREK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD91 POLYPEPTIDE FOR USE IN DETECTING HEMOPEXIN:HEME COMPLEX
    Publication number: 20240101640
    Abstract: The present invention relates to the use of a CD91 polypeptide for detection and quantification of a hemopexin:heme complex in a biological sample, to the use of a CD91 polypeptide for separation of a hemopexin:heme complex from a biological sample and to the monitoring of a hemolysis treatment using a CD91 polypeptide.
    Type: Application
    Filed: August 20, 2021
    Publication date: March 28, 2024
    Inventors: Catherine OWCZAREK, Lisa LINDQVIST, Kirstee MARTIN, Thomas GENTINETTA
  • CD131 binding proteins and uses thereof
    Patent number: 11840573
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: December 12, 2023
    Assignee: CSL LIMITED
    Inventors: Catherine Owczarek, Con Panousis, Nicholas Wilson, Matthew Hardy, Kirsten Edwards, Veronika Rayzman
  • CD131 BINDING PROTEINS AND USES THEREOF
    Publication number: 20210324091
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Application
    Filed: November 20, 2020
    Publication date: October 21, 2021
    Inventors: Catherine OWCZAREK, Kosta PANOUSIS, Nicholas WILSON, Matthew HARDY, Kirsten EDWARDS, Veronika RAYZMAN
  • CD131 binding proteins
    Patent number: 10894834
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: January 19, 2021
    Assignee: CSL LIMITED
    Inventors: Catherine Owczarek, Kosta Panousis, Nicholas Wilson, Matthew Hardy, Kirsten Edwards, Veronika Rayzman
  • CD131 BINDING PROTEINS AND USES THEREOF
    Publication number: 20190062438
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Application
    Filed: November 25, 2016
    Publication date: February 28, 2019
    Inventors: Catherine OWCZAREK, Kosta PANOUSIS, Nicholas WILSON, Matthew HARDY, Kirsten EDWARDS, Veronika RAYZMAN